Virus Eradication- Articles

issn: 2055-66-40 - print

issn 2055-66-59 - online

issn: 2055-66-40 - print

issn 2055-66-59 - online

Issue 1.3

Guest editorial: Children are not small adults

Caroline Foster & Hermione Lyall

Immunological and pharmacological strategies to reactivate HIV-1 from latently infected cells: a possibility for HIV-1 paediatric patients?

M Martinez-Bonet, MI Clemente, MJ Serramia, et al.

CDC

The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children

P Palma, C Foster, P Rojo, et al

Host factors and early treatments to restrict paediatric HIV infection and early disease progression

Ketty Gianesen, Raffaella Petrara, Riccardo Freguja, et al.

Paediatric HIV infection in the ‘omics era: defining transcriptional signatures of viral control and vaccine responses

Nicola Cotugno, Lesley De Armas, Suresh Pallikkuth, et al

admin

Adverse bone health among children and adolescents growing up with HIV

Tavitiya Sudjaritruk & Thanyawee Puthanakit

CDC

Oral PrEP for HIV prevention. It works

Erica Pool, Elaney Youssef, Martin Fisher

HIV-1 co-receptor tropism and disease progression in children and young adults with perinatally acquired HIV-1 infection. The HICCUP Study

C Foster, S Kaye, C Smith, NE Mackie

CDC

HCV treatment in children and young adults with HIV-HCV co-infection in Europe

Anna Turkova, Vania Giacomet, Tessa Goetghebuer, et al

Plasma pharmacokinetics of once-daily abacavir- and lamivudine-containing regimens and week 96 efficacy in HIV-infected Thai children

Torsak Bunupuradah, Passorn Punyahotra, Tim R Cressey, et al

The long-term outcomes of antiretroviral treatment initiated with mono or dual nucleoside reverse transcriptase inhibitors in HIV-1-infected children: an Asian observational study

O Wittawatmongkol, TJ Mohamed, TPK Le, et al

CDC

Soluble CD163 and monocyte populations in response to antiretroviral therapy and in relationship with neuropsychological testing among HIV-infected children

Jintanat Ananworanich, Stephen J Kerr, Tanyathip Jaimulwong, et al

CDC

Treating hepatitis C virus in children: time for a new paradigm

Claire Thorne, Giuseppe Indolfi, Anna Turkova, et al

Ebola in children: a personal perspective

Tejshri Shah

1433927177JVE1-3 Buss and Hurst image.jpg

Carolina Rodrigues/CDC photo library

Viruses and exacerbations of chronic obstructive pulmonary disease: unmet clinical need

Lewis Buss & John Hurst

Second European Round Table on the Future Management of HIV 10–11 October 2014, Barcelona, Spain

Casper Rokx, Douglas Richman, Michaela Mueller-Trutwin, et al.

50th International Liver Congress: update on viral hepatitis 22–26 April 2015, Vienna, Austria

Morven Cunningham & Douglas Macdonald

1435705382Pages from 2016_Keystone_Symposia_1stAnnouncement.jpg

Highlights from the Keystone Symposium on HIV Persistence 2015 26–30 April 2015, Boston, Massachusetts, USA

Sulggi Lee

Highlights from the Children’s HIV Association Conference 22 May 2015, Leicester

Srini Bandi

Control of HIV viraemia is not enough in perinatal HIV

Caroline Foster & Sarah Fidler

Displaying 1 to 20 (of 20 articles)

[Show 6 per page]

issn: 2055-66-40 - print

issn 2055-66-59 - online

issn: 2055-66-40 - print

issn 2055-66-59 - online

Subject

Issues

Issue 1.3

Guest editorial: Children are not small adults

Immunological and pharmacological strategies to reactivate HIV-1 from latently infected cells: a possibility for HIV-1 paediatric patients?

The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children

Host factors and early treatments to restrict paediatric HIV infection and early disease progression

Paediatric HIV infection in the ‘omics era: defining transcriptional signatures of viral control and vaccine responses

Adverse bone health among children and adolescents growing up with HIV

Oral PrEP for HIV prevention. It works

HIV-1 co-receptor tropism and disease progression in children and young adults with perinatally acquired HIV-1 infection. The HICCUP Study

HCV treatment in children and young adults with HIV-HCV co-infection in Europe

Plasma pharmacokinetics of once-daily abacavir- and lamivudine-containing regimens and week 96 efficacy in HIV-infected Thai children

The long-term outcomes of antiretroviral treatment initiated with mono or dual nucleoside reverse transcriptase inhibitors in HIV-1-infected children: an Asian observational study

Soluble CD163 and monocyte populations in response to antiretroviral therapy and in relationship with neuropsychological testing among HIV-infected children

Treating hepatitis C virus in children: time for a new paradigm

Ebola in children: a personal perspective

Viruses and exacerbations of chronic obstructive pulmonary disease: unmet clinical need

Second European Round Table on the Future Management of HIV 10–11 October 2014, Barcelona, Spain

50th International Liver Congress: update on viral hepatitis 22–26 April 2015, Vienna, Austria

Highlights from the Keystone Symposium on HIV Persistence 2015 26–30 April 2015, Boston, Massachusetts, USA

Highlights from the Children’s HIV Association Conference 22 May 2015, Leicester

Control of HIV viraemia is not enough in perinatal HIV

Article Type

Subject

Issues

Issue 1.3

Guest editorial: Children are not small adults

Immunological and pharmacological strategies to reactivate HIV-1 from latently infected cells: a possibility for HIV-1 paediatric patients?

The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children

Host factors and early treatments to restrict paediatric HIV infection and early disease progression

Paediatric HIV infection in the ‘omics era: defining transcriptional signatures of viral control and vaccine responses

Adverse bone health among children and adolescents growing up with HIV

Oral PrEP for HIV prevention. It works

HIV-1 co-receptor tropism and disease progression in children and young adults with perinatally acquired HIV-1 infection. The HICCUP Study

HCV treatment in children and young adults with HIV-HCV co-infection in Europe

Plasma pharmacokinetics of once-daily abacavir- and lamivudine-containing regimens and week 96 efficacy in HIV-infected Thai children

The long-term outcomes of antiretroviral treatment initiated with mono or dual nucleoside reverse transcriptase inhibitors in HIV-1-infected children: an Asian observational study

Soluble CD163 and monocyte populations in response to antiretroviral therapy and in relationship with neuropsychological testing among HIV-infected children

Treating hepatitis C virus in children: time for a new paradigm

Ebola in children: a personal perspective

Viruses and exacerbations of chronic obstructive pulmonary disease: unmet clinical need

Second European Round Table on the Future Management of HIV 10–11 October 2014, Barcelona, Spain

50th International Liver Congress: update on viral hepatitis 22–26 April 2015, Vienna, Austria

Highlights from the Keystone Symposium on HIV Persistence 2015 26–30 April 2015, Boston, Massachusetts, USA

Highlights from the Children’s HIV Association Conference 22 May 2015, Leicester

Control of HIV viraemia is not enough in perinatal HIV